Overview

An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Multicenter trial conducted in Pharmacy retail centers
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Tamsulosin